Patent · US Active

Modified nucleotides

US8597881B2 · kind B2 · utility

46Cited by
71References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2011
Grant dateDec 3, 2013
Priority date
Expiry dateJan 8, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein is a method for replacing the allyl group in a compound of formula R—O-allyl, R2N(allyl), RNH(allyl), RN(allyl)2 or R—S-allyl with a hydrogen, using a transition metal and one or more phosphine ligands.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.